Ole Andreas Halvorsen
Viking Global Investors
Ole Andreas Halvorsen Bristol-Myers Squibb Company stake
total: 670
Viking Global Investors BMY trades
- Total transactions:
- 7
- New positions:
- 1
- Sold out:
- 1
- Added:
- 2
- Reduced:
- 3
- Held since:
- 2020 Q3
- Held for:
- 6 quarters
- Latest activity:
- 2022 Q1
According to 2026 Q2 report, Ole Andreas Halvorsen doesn't hold any Bristol-Myers Squibb Company (BMY) shares. To date, the estimated cost basis is nearly $64.26 for "buy" trades and estimated average "sell" price is $61.19. Viking Global Investors first purchased BMY in 2020 Q3, initially acquiring about 3.19M shares. Since the initial investment in Bristol-Myers Squibb Company (BMY), Viking Global Investors has made 6 more transactions.
When did Ole Andreas Halvorsen sell Bristol-Myers Squibb Company (BMY)?
Ole Andreas Halvorsen sold off the entire Bristol-Myers Squibb Company (BMY) position in 2022 Q1.
When did Ole Andreas Halvorsen buy Bristol-Myers Squibb Company (BMY)?
Ole Andreas Halvorsen first invested in Bristol-Myers Squibb Company (BMY) in 2020 Q3 at the reported quarter-end price of $60.29 per share.
What's the cost basis of Viking Global Investors's BMY stake?
The estimated cost basis for Bristol-Myers Squibb Company (BMY) stake is around $64.26 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $64.26
- Weighted AVG sell price:
- $61.19
Ole Andreas Halvorsen's historical trades in Bristol-Myers Squibb Company
7 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2022 Q1
|
0.00%
|
0
|
$62.35
|
|
-100% (-1,815,619)
|
-0.33%
|
|
2021 Q4
|
0.33%
|
1,815,619
|
$62.35
|
$113,204,000
|
-74.15% (-5,207,645)
|
-0.89%
|
|
2021 Q3
|
1.14%
|
7,023,264
|
$59.17
|
$415,567,000
|
-37.94% (-4,294,488)
|
-0.77%
|
|
2021 Q2
|
2.29%
|
11,317,752
|
$66.82
|
$756,252,000
|
+117.84% (+6,122,279)
|
+1.24%
|
|
2021 Q1
|
0.98%
|
5,195,473
|
$63.13
|
$327,990,000
|
+107.26% (+2,688,680)
|
+0.51%
|
|
2020 Q4
|
0.43%
|
$62.03
|
-21.40% (-682,471)
|
|||
|
2020 Q3
|
0.69%
|
$60.29
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.